Alta Life Sciences — 2020 Investments
4 investments dated 2020 · listed companies and verified rows first · show all
Accure Health is a company focused on developing treatments to improve the lives of patients and their relatives affected by central nervous system (CNS) diseases.
BiotechHealthtech
Laurent Nguyen(CEO)inPablo Villoslada(CSO)inRossella Medori(CMO)inPaul Bikard(CFO)in
Co-investorsAliath BioventuresAsabys PartnersKinled Holding
Deepull develops a multiplex PCR diagnostic system to rapidly identify sepsis-causing pathogens and antibiotic resistance markers directly from blood samples in approximately one hour, targeting hospitals and clinical laboratories.
Medical Devices
Co-investorsAsabys PartnersColumbus Venture Partners
Ona provides cloud-based agent infrastructure that runs developer tasks in isolated environments while laptops are closed, automating workflow execution through events, schedules, and pull requests.
AI & Machine LearningCloud ComputingDeveloper Tools
Co-investorsBright Pixel CapitalCrane Venture PartnersPebblebedPreston-Werner VenturesVertex VenturesAsabys Partners+5 more
Ona Therapeutics develops therapeutic antibodies targeting lipid metabolism to treat advanced and metastatic cancers, including liposarcoma.
BiotechHealthtechMedical Devices
Co-investorsAsabys PartnersFund+KorysMérieux Equity PartnersYsios CapitalBpifrance+2 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.












